To test the hypothesis that temporarily blocking MAdCAM-1 during the critical window for priming of naive autoreactive T cells would inhibit the development of islet inflammation and diabetes, we gave 3-week-old NOD mice one intraperitoneal (ip) injection of anti-MAdCAM-1 or isotype control mAb. The gene discussed is MADCAM1; the disease is diabetes mellitus.